About Us
Management
Our founders, management, are globally acknowledged scientific and drug development leaders whose vision is to make a difference in AML patient care.

Florent Gros
Chief Executive Officer and Founder
READ MORE

Brice Suire
Chief Financial Officer and Founder
READ MORE

Didier Hagenauer
Director Clinical Development
READ MORE

Simone Dertschnig
Research Director
READ MORE
Supervisory Board
Our supervisory board is composed of venture capital leaders from leading international venture funds, also joined by Dr. Dhaval Patel, leader in S1Pr drug developments (Gilenya).

Manus Rogan
Chair
READ MORE

Dhaval Patel
Director
READ MORE

Marten Steen
Director
READ MORE

Henry Skinner
Director
READ MORE

Lionel Carnot
Director
READ MORE
Advisory Board

Christoph Bucher
Head of Clinical Advisory Board
READ MORE

Simone Seiter
Head of Commercial and Scientific Advisory Board
READ MORE